Screening compound: C25H33N5O5 (L575-0656)

Screening compound: C<sub>25</sub>H<sub>33</sub>N<sub>5</sub>O<sub>5</sub> (L575-0656)
Screening compound: C<sub>25</sub>H<sub>33</sub>N<sub>5</sub>O<sub>5</sub> (L575-0656) alternative view

Chemical Structure Depiction of ChemDiv screening compound
C25H33N5O5 (L575-0656)

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

L575-0656

Molecular Formula

C25H33N5O5 (C25 H33 N5 O5)

Compound Name

N-[(2-ethoxyphenyl)methyl]-4-[1-methyl-3-(morpholine-4-carbonyl)-1H,4H,5H,6H,7H-pyrazolo[4,3-c]pyridin-5-yl]-4-oxobutanamide

IUPAC name

N-[(2-ethoxyphenyl)methyl]-4-[1-methyl-3-(morpholine-4-carbonyl)-1H4H5H6H7H-pyrazolo[43-c]pyridin-5-yl]-4-oxobutanamide

SMILES

CCOc1c(CNC(CCC(N(CC2)Cc3c2n(C)nc3C(N2CCOCC2)=O)=O)=O)cccc1

InChI

InChI=1S/C25H33N5O5/c1-3-35-21-7-5-4-6-18(21)16-26-22(31)8-9-23(32)30-11-10-20-19(17-30)24(27-28(20)2)25(33)29-12-14-34-15-13-29/h4-7H,3,8-17H2,1-2H3,(H,26,31)

InChI Key

GDWHASRBLIJXRI-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD27463578

C25H33N5O5 (L575-0656) in Drug Discovery

Included in Screening Libraries

Anticancer Library (62698 compounds)

300k Representative Compounds Library (Bemis-Murcko Clustering Algorithm) (286253 compounds)

Cysteine Proteases Inhibitors Library (7839 compounds)

Hsp90-Targeted Library (11355 compounds)

Adenosine Receptors Targeted Library (19896 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Infections
  • Cancer
  • Musculoskeletal
  • Digestive system
  • Nervous system
  • Cardiovascular
  • Skin
  • Metabolic
  • Endocrine
  • Immune system
  • Cancer
  • Digestive system
  • Respiratory tract
  • Male
  • Female
  • Hemic and lymphatic
  • Immune system
  • Cancer
  • Digestive system
  • Respiratory tract
  • Nervous system
  • Eye
  • Cardiovascular
Targets:
  • Proteases
  • GPCR
Mechanism of action:
  • Receptor's ligands

References: we are preparing a list of scientific research reports with C25H33N5O5 (L575-0656) chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound C25H33N5O5 (L575-0656)?
Check Price and Availability of C25H33N5O5 (L575-0656), then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of C25H33N5O5 (L575-0656) you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for C25H33N5O5 (L575-0656)
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for C25H33N5O5 (L575-0656)
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of C25H33N5O5 (L575-0656) available by request